Abstract: [Problem] To provide: a medicinal composition for treating an AXL related cancer; in another embodiment a medicinal composition for treating a cancer with high expression of AXL; and in still another embodiment a medicinal composition for treating a cancer that has acquired resistance through activation of AXL against anticancer agent therapy. [Solution] As the results of an examination on compounds having AXL inhibitory effect the present inventors confirmed that specific diamino heterocyclic carboxamide compounds have AXL inhibitory effect and medicinal compositions comprising such a compound as an active ingredient have therapeutic effect on an AXL related cancer on a cancer with high expression of AXL in another embodiment and on a cancer that has acquired resistance through activation of AXL against anticancer agent therapy in still another embodiment thereby completing the present invention.
SOFT COPY ATTACHED IN PDF
| # | Name | Date |
|---|---|---|
| 1 | Power of Attorney [03-08-2016(online)].pdf | 2016-08-03 |
| 2 | Form 5 [03-08-2016(online)].pdf | 2016-08-03 |
| 3 | Form 3 [03-08-2016(online)].pdf | 2016-08-03 |
| 4 | Form 1 [03-08-2016(online)].pdf | 2016-08-03 |
| 5 | Drawing [03-08-2016(online)].pdf | 2016-08-03 |
| 6 | Description(Complete) [03-08-2016(online)].pdf | 2016-08-03 |
| 7 | Other Patent Document [29-08-2016(online)].pdf | 2016-08-29 |
| 8 | 201647026442.pdf | 2016-09-17 |
| 9 | 201647026442-Form 1-300816.pdf | 2016-09-28 |
| 10 | 201647026442-Correspondence-F1-300816.pdf | 2016-09-28 |
| 11 | Form 3 [01-02-2017(online)].pdf | 2017-02-01 |
| 12 | Form 3 [05-06-2017(online)].pdf | 2017-06-05 |
| 13 | 201647026442-FORM 18 [09-11-2017(online)].pdf | 2017-11-09 |
| 14 | 201647026442-FORM 3 [20-12-2018(online)].pdf | 2018-12-20 |
| 15 | 201647026442-FER.pdf | 2019-03-29 |
| 16 | 201647026442-AbandonedLetter.pdf | 2019-10-04 |
| 1 | Espacenetpatentsearch_25-03-2019.pdf |